Literature DB >> 19331584

Are all subtypes created equal? The effectiveness of antiretroviral therapy against non-subtype B HIV-1.

Sergei L Kosakovsky Pond, Davey M Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19331584      PMCID： PMC3052852          DOI： 10.1086/598503

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  36 in total

1.  HIV-1 nomenclature proposal.

Authors:  D L Robertson; J P Anderson; J A Bradac; J K Carr; B Foley; R K Funkhouser; F Gao; B H Hahn; M L Kalish; C Kuiken; G H Learn; T Leitner; F McCutchan; S Osmanov; M Peeters; D Pieniazek; M Salminen; P M Sharp; S Wolinsky; B Korber
Journal:  Science       Date:  2000-04-07       Impact factor: 47.728

2.  Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate.

Authors:  Matthew E Harris; David Serwadda; Nelson Sewankambo; Bohye Kim; Godfrey Kigozi; Noah Kiwanuka; James B Phillips; Fred Wabwire; Mary Meehen; Tom Lutalo; James R Lane; Randall Merling; Ron Gray; Maria Wawer; Deborah L Birx; Merlin L Robb; Francine E McCutchan
Journal:  AIDS Res Hum Retroviruses       Date:  2002-11-20       Impact factor: 2.205

Review 3.  Role of genetic diversity amongst HIV-1 non-B subtypes in drug resistance: a systematic review of virologic and biochemical evidence.

Authors:  Jorge L Martínez-Cajas; Nitika Pant-Pai; Marina B Klein; Mark A Wainberg
Journal:  AIDS Rev       Date:  2008 Oct-Dec       Impact factor: 2.500

4.  Running with scissors: using antiretroviral therapy without monitoring viral load.

Authors:  Davey M Smith; Robert T Schooley
Journal:  Clin Infect Dis       Date:  2008-05-15       Impact factor: 9.079

5.  Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization.

Authors:  F Gao; S G Morrison; D L Robertson; C L Thornton; S Craig; G Karlsson; J Sodroski; M Morgado; B Galvao-Castro; H von Briesen; S Beddows; J Weber; P M Sharp; G M Shaw; B H Hahn
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

6.  Human immunodeficiency viruses: SIV infection in wild gorillas.

Authors:  Fran Van Heuverswyn; Yingying Li; Cecile Neel; Elizabeth Bailes; Brandon F Keele; Weimin Liu; Severin Loul; Christelle Butel; Florian Liegeois; Yanga Bienvenue; Eitel Mpoudi Ngolle; Paul M Sharp; George M Shaw; Eric Delaporte; Beatrice H Hahn; Martine Peeters
Journal:  Nature       Date:  2006-11-09       Impact factor: 49.962

7.  The emergence of HIV/AIDS in the Americas and beyond.

Authors:  M Thomas P Gilbert; Andrew Rambaut; Gabriela Wlasiuk; Thomas J Spira; Arthur E Pitchenik; Michael Worobey
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-31       Impact factor: 11.205

8.  Reliability of rapid subtyping tools compared to that of phylogenetic analysis for characterization of human immunodeficiency virus type 1 non-B subtypes and recombinant forms.

Authors:  Africa Holguín; Marisa López; Vincent Soriano
Journal:  J Clin Microbiol       Date:  2008-10-08       Impact factor: 5.948

9.  Human immunodeficiency virus reverse transcriptase and protease sequence database.

Authors:  Soo-Yon Rhee; Matthew J Gonzales; Rami Kantor; Bradley J Betts; Jaideep Ravela; Robert W Shafer
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

10.  Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy.

Authors:  Anna Maria Geretti; Linda Harrison; Hannah Green; Caroline Sabin; Teresa Hill; Esther Fearnhill; Deenan Pillay; David Dunn
Journal:  Clin Infect Dis       Date:  2009-05-01       Impact factor: 9.079
View more
  8 in total

1.  Patients infected with HIV type 1 subtype CRF01_AE and failing first-line nevirapine- and efavirenz-based regimens demonstrate considerable cross-resistance to etravirine.

Authors:  Weerawat Manosuthi; David M Butler; Wasun Chantratita; Chonlaphat Sukasem; Douglas D Richman; Davey M Smith
Journal:  AIDS Res Hum Retroviruses       Date:  2010-06       Impact factor: 2.205

2.  Regional differences in predictive accuracy of WHO immunologic failure criteria.

Authors:  Agnes N Kiragga; Barbara Castelnuovo; Moses R Kamya; Richard Moore; Yukari C Manabe
Journal:  AIDS       Date:  2012-03-27       Impact factor: 4.177

3.  Viral Genetic Diversity and Polymorphisms in a Cohort of HIV-1-Infected Patients Eligible for Initiation of Antiretroviral Therapy in Abuja, Nigeria.

Authors:  Karidia Diallo; Du-Ping Zheng; Erin K Rottinghaus; Orji Bassey; Chunfu Yang
Journal:  AIDS Res Hum Retroviruses       Date:  2015-02-05       Impact factor: 2.205

4.  Molecular epidemiology of HIV-1 clades in Southern Brazil.

Authors:  Sonia Mara Raboni; Sérgio Monteiro de Almeida; Indianara Rotta; Cléa Elisa Lopes Ribeiro; Debra Rosario; Luine Rosele Vidal; Meri Bordignon Nogueira; Maristela Riedel; Maria da Graça Winhescki; Kátia Antunes Ferreira; Ronald Ellis
Journal:  Mem Inst Oswaldo Cruz       Date:  2010-12       Impact factor: 2.743

5.  Selection of nonnucleoside reverse transcriptase inhibitor-associated mutations in HIV-1 subtype C: evidence of etravirine cross-resistance.

Authors:  Ujjwal Neogi; Anita Shet; Ranjani Shamsundar; Maria L Ekstrand
Journal:  AIDS       Date:  2011-05-15       Impact factor: 4.177

6.  Detecting retroviral sequences in chronic fatigue syndrome.

Authors:  Ila R Singh
Journal:  Viruses       Date:  2010-11-03       Impact factor: 5.818

7.  Comparison of methods to detect HIV dual infection.

Authors:  Mary Pacold; Davey Smith; Susan Little; Pok Man Cheng; Parris Jordan; Caroline Ignacio; Douglas Richman; Sergei Kosakovsky Pond
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-18       Impact factor: 1.723

8.  Comparing mutational pathways to lopinavir resistance in HIV-1 subtypes B versus C.

Authors:  Susana Posada-Céspedes; Gert Van Zyl; Hesam Montazeri; Jack Kuipers; Soo-Yon Rhee; Roger Kouyos; Huldrych F Günthard; Niko Beerenwinkel
Journal:  PLoS Comput Biol       Date:  2021-09-07       Impact factor: 4.475
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.